4.2 Article

Production of laccase enzyme from Curvularia lunata MY3: purification and characterization

Journal

FOLIA MICROBIOLOGICA
Volume -, Issue -, Pages -

Publisher

SPRINGER
DOI: 10.1007/s12223-023-01088-2

Keywords

Characterization; Curvularia lunata; Laccase; Purification

Ask authors/readers for more resources

A laccase-producing fungus (MY3) was isolated from soil samples in Egypt, showing higher laccase production compared to other isolated fungi. It was identified as Curvularia lunata MY3 using the molecular technique 18SrRNA. The enzyme was purified using several chromatography techniques, and its properties, such as optimal temperature and pH, stability, and substrate specificity, were determined. The antimicrobial activity of the purified enzyme against pathogenic strains was also evaluated.
Laccase-producing fungus (MY3) was successfully isolated from soil samples collected from Mansoura Governorate, Egypt. This fungal isolate has shown a high laccase production level over other isolated fungi. The identity of this isolate was determined by the molecular technique 18SrRNA as Curvularia lunata MY3. The enzyme purification was performed using ammonium sulfate precipitation followed by Sephacryl S-200 and DEAE-Sepharose column chromatography. The denatured enzyme using SDS-PAGE had a molar mass of 65 kDa. The purified laccase had an optimum temperature at 40 degrees C for enzyme activity with 57.3 kJ/mol activation energy for 2,2'-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) oxidation. The enzyme had an optimum pH of 5.0, and it has shown a high stability at the acidic range (4.5 to 5.5). Mn2+ and Mg2+ ions enhanced the enzyme activity, while most of the enzyme activity was inhibited by Hg2+. Some compounds such as 2-mercaptoethanol, L-cysteine, and sodium azide at a concentration of 10 mmol/L had shown a high suppression effect on the enzyme activity. The enzyme strongly oxidized ABTS and syringaldazine and moderately oxidized DMP and guaiacol. The antimicrobial activity of the purified enzyme towards three pathogenic strains (Escherichia coli ATCC-25922, Staphylococcus aureus NRRLB-767, and Candida albicans ATCC-10231) was evaluated for the potential use as an antimi-crobial therapeutic enzyme.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available